Skip to search formSkip to main contentSkip to account menu

dehydrozingeronolol

Known as: 3-Buten-2-one, 4-(04-(02-hydroxy-3-0(1-methylethyl)amino)propoxy)-3-methoxyphenyl-, 4-(4'-(2-hydroxy-3-(isopropylamino)propoxy)-3'-methoxyphenyl)-3-buten-2-one, 4-DZPN 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Propanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
A new beta-adrenoceptor blocking agent derived from dehydrozingerone.
1. Dehydrozingeronolol (DZPN; 0.1, 0.5, 1.0 mg/kg, i.v.) produced a dose-dependent bradycardia response and a sustained pressor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)